Disclosed are novel compounds of formula (I) wherein R1, R2 and R3 are as defined herein, which are useful as inhibitors of PKC-theta and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC-theta, including immunological disorders and type II diabetes. This invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders and processes for preparing these compounds.
揭示了一种新型的化合物,其
化学式为(I),其中R1、R2和R3如本文所定义,这些化合物可作为PKC-theta的
抑制剂,因此可用于治疗各种通过PKC-theta活性介导或维持的疾病和疾病,包括免疫性疾病和2型糖尿病。该发明还涉及包含这些化合物的药物组合物,使用这些化合物治疗各种疾病和疾病的方法以及制备这些化合物的过程。